Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ecuador
Ecuador: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 76.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ecuador, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Ecuador is 76.0%, measured in 2025.
Compared with earlier readings it is down 11.6% on the previous year and down 6.2% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Ecuador peaked at 94.0% in 2012 and was at its lowest, 0.0%, in 2008.
That places Ecuador 128th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ecuador, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 17.0% | — |
| 2011 | 71.0% | +317.6% |
| 2012 | 94.0% | +32.4% |
| 2013 | 90.0% | -4.3% |
| 2014 | 86.0% | -4.4% |
| 2015 | 81.0% | -5.8% |
| 2016 | 84.0% | +3.7% |
| 2017 | 84.0% | +0.0% |
| 2018 | 85.0% | +1.2% |
| 2019 | 83.0% | -2.4% |
| 2020 | 76.0% | -8.4% |
| 2021 | 62.0% | -18.4% |
| 2022 | 71.0% | +14.5% |
| 2023 | 79.0% | +11.3% |
| 2024 | 86.0% | +8.9% |
| 2025 | 76.0% | -11.6% |
Ecuador compared with similar countries
- Ecuador's 76.0% is above the median for upper middle income countries, which is 76.0%, 1.0× the median. (57 countries reporting)
- Ecuador's 76.0% is below the median for Latin America & Caribbean, which is 82.5%, 92% of the median. (32 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ecuador changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2011 | +317.6% | 17.0% | 71.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 77.5% | 17.0% | 94.0% | 10 |
| 2020s | 75.0% | 62.0% | 86.0% | 6 |
Countries ranked near Ecuador
More health data for Ecuador
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6766 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,324 deaths per 1,000 people (2090)
- Number of infants who die before age 1 354 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0362 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Ecuador?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Ecuador was 76.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Ecuador?
- The highest recorded value was 94.0% in 2012.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Ecuador?
- The lowest recorded value was 0.0% in 2008.
- How does Ecuador rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Ecuador ranks 128th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Ecuador?
- Over the last ten years it is down 6.2%. The long-run trend across the full record is rising.
- Where does this Ecuador data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).